ZIVO — Zivo Bioscience, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1101026 ·
Last close
$3.30
Market Cap
$13.91M
52W High
$17.50
52W Low
$1.11
ADV30
510
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 65,625 | 21,288 | -1,018,343 | -1,033,056 | 559,452 | 57,222 | 3,846,055 |
| Jun 2025 | 53,400 | 17,922 | -1,632,872 | -1,640,232 | 703,327 | 9,823 | 3,244,073 |
| Mar 2025 | 0 | 0 | -4,208,788 | -4,211,188 | 1,331,334 | 517,189 | 2,948,613 |
| Dec 2024 | 90,000 | 27,000 | -1,596,419 | -1,601,385 | 1,643,122 | 1,542,442 | 2,158,019 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,078,926
Investing CF
$0
Financing CF
$2,976,745
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.82
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-143,851,025
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-8,458,176
Pretax Income TTM
$-8,485,861
Interest Exp TTM
$27,685
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$209,025
EBITDA
—
Free Cash Flow
$-2,617,243
Enterprise Value
$16,705,712
Total Cash
$57,222
Total Debt
$819,695
Shares Out
4,215,112
Trailing EPS
$-2.18
Book Value
$-0.86
ROE
—
ROA
-1001.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 157,220 | -13,361,897 | -13,384,836 | 1,643,122 | 2,158,019 | -514,897 | -4,313,510 |
| Dec 2023 | 27,650 | -7,263,012 | -7,777,184 | 555,715 | 2,761,558 | -2,205,843 | -5,799,893 |
| Dec 2022 | 0 | -8,731,974 | -8,745,293 | 2,123,019 | 2,133,641 | -10,622 | -7,102,612 |
| Dec 2021 | 0 | -8,645,119 | -8,755,881 | 8,990,178 | 2,947,969 | 6,042,209 | -6,803,333 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.20
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CKDXF | Opthea Ltd | $13.68M | $0.01 | — |
| PASG | Passage BIO, Inc. | $15.45M | $4.80 | — |
| PLUR | Pluri Inc. | $12.47M | $1.01 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | $12.41M | $3.80 | — |
| BCDA | BioCardia, Inc. | $15.90M | $1.05 | — |
News headlines (Yahoo Finance, 1h cache)
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
2026-06-26 12:35 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
2026-06-23 12:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.